Frontiers of Metabolomics Research
Metabolomic studies can provoke enhanced perception of disease instruments and to new demonstrative markers and furthermore redesigned understanding of medication for solution or xenobiotic impact and expanded capacity to foresee singular variety in sedate reaction phenotypes. Howard University Center for Computational Biology and Bioinformatics (CCBB) is to invigorate and propel the usage of computational approaches to manage the examination of biomedical and disease shapes. New programming and progressively advanced NMR metabolite ghastly databases are driving the fascinating limits of NMR spectroscopy to perceive and assess little particles in respond in due order regarding examinations of metabolite biomarkers and metabolic motion. NIH Awards $1.6M to Fund microRNA Biomarker Research in Cancer, Alzheimer's Disease . The Bill and Melinda Gates Foundation today revealed $7.7 million in sponsoring for 10 new permits to recognize biomarkers for diagnosing tuberculosis (TB) in low-resource settings. NMR metabolomics to exhibit that disparate natural signs are transduced into regular metabolomic changes that are "detected" by metabolite responsive controllers.
- Systems Biology approach in regulation of biochemical processes
- Stem cell metabolism
- Biomedical applications of computational NMR
- Metabolomics screening
- Signal transduction
- Biomarkers research
Related Conference of Frontiers of Metabolomics Research
Frontiers of Metabolomics Research Conference Speakers
Recommended Sessions
- Analytical Platforms in Metabolomics
- Case Reports
- Clinical Metabolomics & Lipidomics
- Frontiers of Metabolomics Research
- Human Metabolomics
- Mass Spectrometry based Metabolomics
- Metabolic Modelling
- Metabolic Syndrome
- Metabolomic Analysis
- Metabolomic Devices
- Metabolomic profiling
- Metabolomics and Cancer Research
- Metabolomics in Precision Medicine
- Plant & Environmental Metabolomics
- Protein Expression and Analysis
- Proteomics and its Medicinal Research
- Proteomics for Bioinformatics
- Proteomics from Discovery to Function
- Single Cell Metabolomics
- Urine Metabolomics
Related Journals
Are you interested in
- 3D Structure Determination - Structural Biology-2026 (France)
- Advanced Drug Delivery Systems for Metabolic Therapy - DRUG CHEMISTRY CONF 2026 (France)
- Advanced Techniques in Structural Biology - Structural Biology-2026 (France)
- AI & Computational Structural Biology - Structural Biology-2026 (France)
- Biochemistry and Biophysics - Structural Biology-2026 (France)
- Biomarker-Guided Drug Development - DRUG CHEMISTRY CONF 2026 (France)
- Chemical Biology Tools in Metabolic Research - DRUG CHEMISTRY CONF 2026 (France)
- Computational Approach in Structural Biology - Structural Biology-2026 (France)
- Computational Drug Design and Molecular Modeling - DRUG CHEMISTRY CONF 2026 (France)
- Drug Designing and Biomarkers - Structural Biology-2026 (France)
- Drug Resistance and Therapeutic Durability - DRUG CHEMISTRY CONF 2026 (France)
- Enzyme Modulation Approaches in Antidiabetic Drug Design - DRUG CHEMISTRY CONF 2026 (France)
- Epigenetic Regulation and Small-Molecule Therapeutics - DRUG CHEMISTRY CONF 2026 (France)
- Future Directions in Drug Chemistry for Diabetes Management - DRUG CHEMISTRY CONF 2026 (France)
- Hybrid Approaches for Structure Prediction - Structural Biology-2026 (France)
- Lipid Chemistry and Metabolic Regulation - DRUG CHEMISTRY CONF 2026 (France)
- Medicinal Chemistry Strategies for Metabolic Disorders - DRUG CHEMISTRY CONF 2026 (France)
- Membrane Proteins and Receptors - Structural Biology-2026 (France)
- Molecular Modelling and Dynamics - Structural Biology-2026 (France)
- Natural Product Chemistry in Diabetes Drug Discovery - DRUG CHEMISTRY CONF 2026 (France)
- Oxidative Stress Modulation through Drug Chemistry - DRUG CHEMISTRY CONF 2026 (France)
- Peptide and Protein-Based Drug Chemistry - DRUG CHEMISTRY CONF 2026 (France)
- Pharmacokinetics and Drug Metabolism Studies - DRUG CHEMISTRY CONF 2026 (France)
- Prodrug Design and Chemical Activation Strategies - DRUG CHEMISTRY CONF 2026 (France)
- Proteomics and Genomics - Structural Biology-2026 (France)
- Regulatory Chemistry and Drug Safety Assessment - DRUG CHEMISTRY CONF 2026 (France)
- Structural Bioinformatics and Computational Biology - Structural Biology-2026 (France)
- Structural Biology in Cancer Research - Structural Biology-2026 (France)
- Structural Virology - Structural Biology-2026 (France)
- Structural Virology and Infectious Diseases - Structural Biology-2026 (France)
- Structure-Based Drug Discovery - Structural Biology-2026 (France)
- Structure-Based Solutions to Global Health Challenges - Structural Biology-2026 (France)
- Structure-Function Relationships - Structural Biology-2026 (France)
- Structure–Activity Relationship Studies in Drug Chemistry - DRUG CHEMISTRY CONF 2026 (France)
- Synthetic Chemistry Innovations in Drug Development - DRUG CHEMISTRY CONF 2026 (France)
- Targeting Pancreatic Function through Drug Chemistry - DRUG CHEMISTRY CONF 2026 (France)
- The Structural Basis of Disease - Structural Biology-2026 (France)
- Translational Drug Chemistry from Bench to Clinic - DRUG CHEMISTRY CONF 2026 (France)
